Literature DB >> 22084251

Multiple site acetylation of Rictor stimulates mammalian target of rapamycin complex 2 (mTORC2)-dependent phosphorylation of Akt protein.

Emily J Glidden1, Lisa G Gray, Suneil Vemuru, Duo Li, Thurl E Harris, Marty W Mayo.   

Abstract

The serine/threonine protein kinase Akt is a critical regulator of cell growth and survival in response to growth factors. A key step in Akt activation is phosphorylation at Ser-473 by the mammalian target of rapamycin (mTOR) complex 2 (mTORC2). Although Rictor is required for the stability and activity of mTORC2, little is known about functional regions or post-translational modifications within Rictor that are responsible for regulating mTORC2. Here, we demonstrate that Rictor contains two distinct central regions critical for mTORC2 function. One we refer to as the stability region because it is critical for interaction with Sin1.1 and LST8, and a second adjacent region is required for multisite acetylation. p300-mediated acetylation of Rictor increases mTORC2 activity toward Akt, whereas site-directed mutants within the acetylation region of Rictor exhibit reduced insulin-like growth factor 1 (IGF-1)-stimulated mTORC2 kinase activity. Inhibition of deacetylases, including the NAD+-dependent sirtuins, promotes Rictor acetylation and IGF-1-mediated Akt phosphorylation. These results suggest that multiple-site acetylation of Rictor signals for increased activation of mTORC2, providing a critical link between nutrient-sensitive deacetylases and mTORC2 signaling to Akt.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22084251      PMCID: PMC3249112          DOI: 10.1074/jbc.M111.304337

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Akt activation by growth factors is a multiple-step process: the role of the PH domain.

Authors:  A Bellacosa; T O Chan; N N Ahmed; K Datta; S Malstrom; D Stokoe; F McCormick; J Feng; P Tsichlis
Journal:  Oncogene       Date:  1998-07-23       Impact factor: 9.867

2.  Amino acids activate mammalian target of rapamycin complex 2 (mTORC2) via PI3K/Akt signaling.

Authors:  Irantzu Tato; Ramon Bartrons; Francesc Ventura; Jose Luis Rosa
Journal:  J Biol Chem       Date:  2010-12-03       Impact factor: 5.157

3.  Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB.

Authors:  L V Madrid; C Y Wang; D C Guttridge; A J Schottelius; A S Baldwin; M W Mayo
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

4.  Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha.

Authors:  D R Alessi; S R James; C P Downes; A B Holmes; P R Gaffney; C B Reese; P Cohen
Journal:  Curr Biol       Date:  1997-04-01       Impact factor: 10.834

5.  Mechanism of activation of protein kinase B by insulin and IGF-1.

Authors:  D R Alessi; M Andjelkovic; B Caudwell; P Cron; N Morrice; P Cohen; B A Hemmings
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

Review 6.  Signaling by insulin-like growth factor 1 in brain.

Authors:  Carolyn A Bondy; Clara M Cheng
Journal:  Eur J Pharmacol       Date:  2004-04-19       Impact factor: 4.432

7.  Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: the phosphatidylinositol 3-kinase/Akt and Raf/ERK pathways transmit opposing signals.

Authors:  Donglei Zhang; Menashe Bar-Eli; Sylvain Meloche; Pnina Brodt
Journal:  J Biol Chem       Date:  2004-03-01       Impact factor: 5.157

Review 8.  The Sir2 family of protein deacetylases.

Authors:  Gil Blander; Leonard Guarente
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

9.  Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase.

Authors:  Fan Yeung; Jamie E Hoberg; Catherine S Ramsey; Michael D Keller; David R Jones; Roy A Frye; Marty W Mayo
Journal:  EMBO J       Date:  2004-05-20       Impact factor: 11.598

Review 10.  Sirtuins: Sir2-related NAD-dependent protein deacetylases.

Authors:  Brian J North; Eric Verdin
Journal:  Genome Biol       Date:  2004-04-28       Impact factor: 13.583

View more
  39 in total

Review 1.  Stem cell guidance through the mechanistic target of rapamycin.

Authors:  Kenneth Maiese
Journal:  World J Stem Cells       Date:  2015-08-26       Impact factor: 5.326

2.  Hepatic FOXO1 Target Genes Are Co-regulated by Thyroid Hormone via RICTOR Protein Deacetylation and MTORC2-AKT Protein Inhibition.

Authors:  Brijesh K Singh; Rohit A Sinha; Jin Zhou; Madhulika Tripathi; Kenji Ohba; Mu-En Wang; Inna Astapova; Sujoy Ghosh; Anthony N Hollenberg; Karine Gauthier; Paul M Yen
Journal:  J Biol Chem       Date:  2015-10-09       Impact factor: 5.157

3.  Loss of GCN5L1 in cardiac cells disrupts glucose metabolism and promotes cell death via reduced Akt/mTORC2 signaling.

Authors:  Janet R Manning; Dharendra Thapa; Manling Zhang; Michael W Stoner; Javier Traba; Catherine Corey; Sruti Shiva; Michael N Sack; Iain Scott
Journal:  Biochem J       Date:  2019-06-19       Impact factor: 3.857

Review 4.  Receptor tyrosine kinase (RTK) signalling in the control of neural stem and progenitor cell (NSPC) development.

Authors:  Alexander Annenkov
Journal:  Mol Neurobiol       Date:  2013-08-28       Impact factor: 5.590

5.  Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance.

Authors:  Kenta Masui; Kazuhiro Tanaka; Shiro Ikegami; Genaro R Villa; Huijun Yang; William H Yong; Timothy F Cloughesy; Kanato Yamagata; Nobutaka Arai; Webster K Cavenee; Paul S Mischel
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

6.  A Critical Kinase Cascade in Neurological Disorders: PI 3-K, Akt, and mTOR.

Authors:  Zhao Zhong Chong; Yan Chen Shang; Shaohui Wang; Kenneth Maiese
Journal:  Future Neurol       Date:  2012-11

Review 7.  Overnutrition, mTOR signaling, and cardiovascular diseases.

Authors:  Guanghong Jia; Annayya R Aroor; Luis A Martinez-Lemus; James R Sowers
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-09-24       Impact factor: 3.619

8.  An mTOR anti-sense oligonucleotide decreases polycystic kidney disease in mice with a targeted mutation in Pkd2.

Authors:  Kameswaran Ravichandran; Iram Zafar; Zhibin He; R Brian Doctor; Radu Moldovan; Adam E Mullick; Charles L Edelstein
Journal:  Hum Mol Genet       Date:  2014-05-08       Impact factor: 6.150

9.  Mammalian target of rapamycin complex 2 (mTORC2) controls glycolytic gene expression by regulating Histone H3 Lysine 56 acetylation.

Authors:  Raghavendra Vadla; Devyani Haldar
Journal:  Cell Cycle       Date:  2018-01-08       Impact factor: 4.534

Review 10.  Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.

Authors:  Kenneth Maiese
Journal:  Br J Clin Pharmacol       Date:  2015-12-26       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.